Skip to search formSkip to main contentSkip to account menu

Prevnar 13

Known as: PCV-13 vaccine, prevenar 13, PCV13 vaccine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

13-valent pneumococcal vaccinePneumococcal 13-valent conjugate vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Vaccine failures in pediatric cases caused by streptococcus pneumoniae serotype 19A
ABSTRACT Community-acquired pneumonia (CAP) is a leading cause of childhood mortality and morbidity worldwide. PCV-13 has… 
2019
2019
2715. Pneumococcal Community-Acquired Pneumonia Attributed to PCV13 Serotypes in Hospitalized Adults: Comparison of the 50–64 and 65+ Age Groups
Abstract Background In healthy adults aged ≥65 years, direct immunization with the 13-valent pneumococcal conjugate vaccine… 
2018
2018
Résultats préliminaires d’une convention CHU – CPAM permettant la prise en charge des vaccins administrés aux patients à l’hôpital
2017
2017
Ex vivo antigen-pulsed PBMCs generate potent and long lasting immunity to infection when administered as a vaccine.
2017
2017
Rapid kinetics of serum IgA after vaccination with Prevnar®13 followed by Pneumovax®23
2016
2016
Complications of Pneumococcal Bacteremia After Thirteen-valent Conjugate Vaccine Withdrawal
Background: In the Region of Madrid, universal immunization with the 13-serotypes pneumococcal conjugate vaccine (PCV13) started… 
2016
2016
Fieber, Kopfschmerzen und Apathie bei einer 4½-jährigen Patientin mit homozygoter Sichelzellkrankheit
ZusammenfassungWir beschreiben den Fall eines 4½-jährigen Mädchens mit funktioneller Asplenie bei homozygoter Sichelzellkrankheit… 
2015
2015
Chikungunya Virus Infections.
2014
2014
Evidence of a clonal expansion of Streptococcus pneumoniae serotype 19A in adults as in children assessed by the DiversiLab® system
Streptococcus pneumoniae serotype 19A was the main serotype responsible for invasive pneumococcal disease (IPD) in the Paris area… 
2010
2010
Australian Public Assessment Report for Pneumococcal Polysaccharide Conjugate Vaccine Proprietary Product
  • 2010
  • Corpus ID: 32990555
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)